From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Quinestrol molecule ball.png
Clinical data
Trade namesEstrovis, others
SynonymsQuinoestrol; Ethinylestradiol 3-cyclopentyl ether; EE2CPE; W-3566; 3-(Cyclopentyloxy)-17α-ethynylestra-1,3,5(10)-trien-17β-ol
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
By mouth
Drug classEstrogen; Estrogen ether
ATC code
  • None
Pharmacokinetic data
Elimination half-life>120 hours (>5 days)[1]
CAS Number
PubChem CID
ECHA InfoCard100.005.277 Edit this at Wikidata
Chemical and physical data
Molar mass364.52 g/mol
3D model (JSmol)

Quinestrol, sold under the brand name Estrovis among others, is an estrogen medication which has been used in menopausal hormone therapy, hormonal birth control, and to treat breast cancer and prostate cancer.[2][3] It is taken once per week to once per month by mouth.[4][5][6][7]

Medical uses[edit]

Quinestrol has been used as the estrogen component in menopausal hormone therapy and in combined hormonal birth control.[2][3] It has also occasionally been used in the treatment of breast cancer and prostate cancer.[2][3] On its own as an estrogen, quinestrol was taken once per week by mouth.[4] As a combined birth control pill, it was used together with quingestanol acetate and was taken once per month by mouth.[5][6][7]


Ethinylestradiol (EE), the active form of quinestrol.

Quinestrol is a prodrug of ethinylestradiol (EE), with no estrogenic activity of its own.[3][8][9] It is taken orally and has prolonged activity following a single dose,[8][9] with a very long biological half-life of more than 120 hours (5 days) due to enhanced lipophilicity and storage in fat.[3][1] Because of its much longer half-life, quinestrol is two to three times as potent as EE.[3][3] Also because of its long half-life, quinestrol can be taken once a week or once a month.[3][4][5][6][7]

Oral potencies of estrogens

Estrogen Type EPD
(mg/14 days)
(mg/14 days)
Estradiol (micronized) Bioidentical 60 4.3 14–28 1.0–2.0
Estradiol valerate Bioidentical 60 4.3 14–28 1.0–2.0
Estriol Bioidentical 140–150a 10.0–10.7a 28–84 2.0–6.0
Estriol succinate Bioidentical 140–150a 10.0–10.7a 28–84 2.0–6.0
Conjugated estrogens Natural 60 4.3 8.4–17.5 0.6–1.25
Ethinylestradiol Synthetic 1.0–1.5 0.071–0.11 0.28 0.02
Mestranol Synthetic 1.5–2.0 0.11–0.13 0.35 0.025
Quinestrol Synthetic 2.0–4.0 0.14–0.29 ND ND
Diethylstilbestrol Synthetic 20–30 1.4–2.1 ND ND
Diethylstilbestrol dipropionate Synthetic 15–20 1.1–1.4 ND ND
Dienestrol diacetate Synthetic 40–60 2.9–4.3 ND ND
Addendum: The ovulation-inhibiting dose (OID) of ethinylestradiol is 0.1 mg/day.[10] Footnotes: a = Taken in divided doses three times per day. Abbreviations: EPD = Endometrial proliferation dose. MSD = Menopausal substitution dose. Sources: [11][12][13][14]


Quinestrol, also known as ethinylestradiol 3-cyclopentyl ether (EE2CPE), is a synthetic estrane steroid and a derivative of estradiol.[15][16] It is an estrogen ether, specifically the C3 cyclopentyl ether of ethinylestradiol (17α-ethynylestradiol).[15][16] Closely related estrogens include mestranol (ethinylestradiol 3-methyl ether) and ethinylestradiol sulfonate (EES; Turisteron; ethinylestradiol 3-isopropylsulfonate).[15][16]


Quinestrol was developed and introduced for medical use in the 1960s.[17]

Society and culture[edit]

Generic names[edit]

Quinestrol is the generic name of the drug and its INN, USAN, and BAN.[15][16][18][19] It is also known by its former developmental code name W-3566.[15][16][18][19]

Brand names[edit]

Quinestrol has been marketed under brand names including Agalacto-Quilea, Basaquines, Eston, Estrovis, Estrovister, Plestrovis, Qui-Lea, Soluna, and Yueketing, among others.[15][16][18][19]


Quinestrol was marketed as Estrovis in the United States by Parke-Davis and as Qui-Lea in Argentina,[16] but is reportedly not currently marketed.[3] However, it does appear to still be available as an oral contraceptive in combination with progestins in Argentina and China.[19]

One tablet form available in China consists of 6 mg levonorgestrel and 3 mg quinestrol; it is used as a prescription "long-term" oral contraceptive, with one dose taken each month.[19][20] It is sold under various brand names including Yuèkětíng (Chinese: 悦可婷) and Àiyuè (Chinese: 艾悦). A version with the racemic norgestrel in place of levonorgestrel also appears to be available.[19]


  1. ^ a b Michael Oettel; Ekkehard Schillinger (6 December 2012). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen. Springer Science & Business Media. pp. 248–. ISBN 978-3-642-60107-1.
  2. ^ a b c Christoph Zink (1 January 1988). Dictionary of Obstetrics and Gynecology. Walter de Gruyter. pp. 204–. ISBN 978-3-11-085727-6.
  3. ^ a b c d e f g h i A. Wayne Meikle (1 June 1999). Hormone Replacement Therapy. Springer Science & Business Media. pp. 381–. ISBN 978-1-59259-700-0.
  4. ^ a b c H.J. Buchsbaum (6 December 2012). The Menopause. Springer Science & Business Media. pp. 60–. ISBN 978-1-4612-5525-3.
  5. ^ a b c J. Horsky; J. Presl (6 December 2012). Ovarian Function and its Disorders: Diagnosis and Therapy. Springer Science & Business Media. pp. 85, 358, 367. ISBN 978-94-009-8195-9.
  6. ^ a b c D F Hawkins; M G Elder (22 October 2013). Human Fertility Control: Theory and Practice. Elsevier Science. pp. 92–94. ISBN 978-1-4831-6361-1.
  7. ^ a b c Chemical Contraception. Macmillan International Higher Education. 18 June 1974. pp. 61–. ISBN 978-1-349-02287-8.
  8. ^ a b Epstein JA (1967). "Prolonged menstrual response of patients with gonadal failure following quinestrol administration". Int. J. Fertil. 12 (2): 181–6. PMID 6033895.
  9. ^ a b Giannina T, Meli A (April 1969). "Prolonged oestrogenic activity in rats after single oral administration of ethinyloestradiol-3-cyclopentyl ether". J. Pharm. Pharmacol. 21 (4): 271–2. doi:10.1111/j.2042-7158.1969.tb08247.x. PMID 4390151.
  10. ^ N. Rietbrock; A.H. Staib; D. Loew (11 March 2013). Klinische Pharmakologie: Arzneitherapie. Springer-Verlag. pp. 426–. ISBN 978-3-642-57636-2.
  11. ^ Lauritzen C (September 1990). "Clinical use of oestrogens and progestogens". Maturitas. 12 (3): 199–214. doi:10.1016/0378-5122(90)90004-P. PMID 2215269.
  12. ^ Alfred S. Wolf; H.P.G. Schneider (12 March 2013). Östrogene in Diagnostik und Therapie. Springer-Verlag. pp. 78–. ISBN 978-3-642-75101-1.
  13. ^ Gunther Göretzlehner; Christian Lauritzen; Thomas Römer; Winfried Rossmanith (1 January 2012). Praktische Hormontherapie in der Gynäkologie. Walter de Gruyter. pp. 44–. ISBN 978-3-11-024568-4.
  14. ^ Karl Knörr; Fritz K. Beller; Christian Lauritzen (17 April 2013). Lehrbuch der Gynäkologie. Springer-Verlag. pp. 212–213. ISBN 978-3-662-00942-0.
  15. ^ a b c d e f J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 522–. ISBN 978-1-4757-2085-3.
  16. ^ a b c d e f g Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 905–. ISBN 978-3-88763-075-1.
  17. ^ Medical Gynaecology and Sociology. Medical and Scientific Services Limited. 1967. [...] J. Fertil., 1967, 12, 2) contains 23 papers presented at a symposium on QUINESTROL. Quinestrol is a newly-developed synthetic steroid, and is the cyclo-pentyl ether of a ethinyl oestradiol.
  18. ^ a b c I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 243–. ISBN 978-94-011-4439-1.
  19. ^ a b c d e f https://www.drugs.com/international/quinestrol.html
  20. ^ "悦可婷 左炔诺孕酮炔雌醚片 6片/盒". Tmall. Archived from the original on 2018-07-16. Retrieved 2018-07-16. 初次服药时,于月经来潮的当天算起第五天午饭后服药一次,间隔20天服第二次,以后就以第二次服药日为每月的服药日期,每月服一片。原服用短效口服避孕药改服长效避孕药时,可在服完22片后的第二天接服长效避孕药一片,以后每月按开始服长效避孕药的同一日期服药一片。